MET vs. AFL, PRU, UNM, PRI, LNC, CNO, NWLI, CIA, MFC, and SLF
Should you be buying MetLife stock or one of its competitors? The main competitors of MetLife include Aflac (AFL), Prudential Financial (PRU), Unum Group (UNM), Primerica (PRI), Lincoln National (LNC), CNO Financial Group (CNO), National Western Life Group (NWLI), Citizens (CIA), Manulife Financial (MFC), and Sun Life Financial (SLF). These companies are all part of the "finance" sector.
MetLife (NYSE:MET) and Aflac (NYSE:AFL) are both large-cap finance companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, institutional ownership, community ranking, dividends, media sentiment and earnings.
Aflac has a net margin of 27.67% compared to MetLife's net margin of 3.50%. MetLife's return on equity of 20.39% beat Aflac's return on equity.
MetLife received 360 more outperform votes than Aflac when rated by MarketBeat users. Likewise, 73.64% of users gave MetLife an outperform vote while only 57.19% of users gave Aflac an outperform vote.
89.8% of MetLife shares are owned by institutional investors. Comparatively, 67.4% of Aflac shares are owned by institutional investors. 0.3% of MetLife shares are owned by company insiders. Comparatively, 0.9% of Aflac shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
MetLife pays an annual dividend of $2.18 per share and has a dividend yield of 2.9%. Aflac pays an annual dividend of $2.00 per share and has a dividend yield of 2.1%. MetLife pays out 74.9% of its earnings in the form of a dividend. Aflac pays out 22.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.
MetLife has a beta of 1.11, suggesting that its share price is 11% more volatile than the S&P 500. Comparatively, Aflac has a beta of 0.95, suggesting that its share price is 5% less volatile than the S&P 500.
In the previous week, Aflac had 1 more articles in the media than MetLife. MarketBeat recorded 22 mentions for Aflac and 21 mentions for MetLife. Aflac's average media sentiment score of 0.65 beat MetLife's score of 0.65 indicating that Aflac is being referred to more favorably in the news media.
MetLife currently has a consensus target price of $81.08, suggesting a potential upside of 6.68%. Aflac has a consensus target price of $86.46, suggesting a potential downside of 8.82%. Given MetLife's stronger consensus rating and higher probable upside, equities research analysts plainly believe MetLife is more favorable than Aflac.
Aflac has lower revenue, but higher earnings than MetLife. Aflac is trading at a lower price-to-earnings ratio than MetLife, indicating that it is currently the more affordable of the two stocks.
Summary
MetLife beats Aflac on 11 of the 20 factors compared between the two stocks.
Get MetLife News Delivered to You Automatically
Sign up to receive the latest news and ratings for MET and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MET and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
Free MET Stock Alerts